医学
甲状腺癌
甲状腺球蛋白
内科学
胃肠病学
进行性疾病
甲状腺乳突癌
甲状腺癌
癌症
甲状腺
实体瘤疗效评价标准
内分泌学
外科
肿瘤科
疾病
作者
Steven I. Sherman,Lori J. Wirth,Jean-Pierre Droz,Michael Hofmann,Lars Bastholt,Renato Martins,Lisa Licitra,Michael Eschenberg,Yu-Nien Sun,Todd Juan,Daniel E. Stepan,Martin Schlumberger
摘要
The expression of vascular endothelial growth factor (VEGF) is characteristic of differentiated thyroid cancer and is associated with aggressive tumor behavior and a poor clinical outcome. Motesanib diphosphate (AMG 706) is a novel oral inhibitor of VEGF receptors, platelet-derived growth-factor receptor, and KIT.
科研通智能强力驱动
Strongly Powered by AbleSci AI